Catalyst Wire Dossier Catalyst Wire Dossier

CR500 SINGLE-DOSE GEL

· Contrad Swiss SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CR500 SINGLE-DOSE GEL, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Retrospective Evaluation of the Long-term Effectiveness of the CR500™ SINGLE-DOSE GEL Medical Device in Patients With Knee Osteoarthritis (KOA)

See pricing